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All about the money
It’s ﬁ nally 2015: a year by the end of which extreme 
poverty and hunger are to be eradicated, maternal and 
child mortality are to be drastically reduced, and the 
trajectory of the global incidence of HIV, tuberculosis, and 
malaria are to be reversed. Much has been written about 
where the Millennium Development Goals succeeded 
and failed as global targets, and what has changed in 
the world since 2000. Much work has also been done to 
establish what happens next. In his synthesis report on 
the post-2015 agenda released last month, UN Secretary-
General Ban Ki-Moon summarised and annotated this 
work, ultimately backing the 17 goals proposed by the 
Open Working Group on Sustainable Development Goals 
as the basis for a truly transformative agenda. He also 
devoted a hefty chunk of the report to the somewhat less 
exciting subject of how to pay for it.
The International Conference on Financing for Develop-
ment in July marks the ﬁ rst of three key meetings on 
the post-2015 agenda taking place this year (the others 
being the special UN summit in September and the 
21st Conference of the Parties of the UN Framework 
Convention on Climate Change [COP21] in December). The 
conference will take as its starting point the report of the 
Intergovernmental Committee of Experts on Sustainable 
Development Financing, which lays out policy options for 
the four main sources of development ﬁ nance—national 
public sources (eg, tax income), national private sources 
(eg, bank credit), international public sources (eg, oﬃ  cial 
development assistance [ODA]), and international private 
sources (eg, trade and foreign investment). Some of the 
need for ﬁ nancing reform is explored in this month’s issue.
In a Comment, Bernadette O’Hare highlights the 
iniquitous tax exemptions granted to foreign mining 
and agribusiness companies in Sierra Leone—a country 
whose disastrously underfunded health system 
has been cast into the spotlight by the Ebola crisis. 
Designed to attract investment in the country, often in 
competition with neighbouring countries, such policies 
can result in “a race to the bottom”, O’Hare states, 
“with multinational companies being the beneﬁ ciaries 
and the population being the losers”. The importance 
of a joined-up and fair approach to national and 
international tax policy cannot be overstated.
In a further Comment, Alexander Kentikelenis and 
colleagues point to problems with the lending policies 
of international ﬁ nancial institutions such as the Inter-
national Monetary Fund (IMF). The IMF inﬂ uences 
national ﬁ nancing policies by issuing conditional loans. 
Kentikelenis and colleagues contend that IMF conditions 
constrained domestic spending in the years leading up 
to the Ebola crisis in Sierra Leone, Guinea, and Liberia, 
including on health, and contributed to the health work-
force crisis by capping the public-sector wage bill. The IMF’s 
Sanjeev Gupta responds robustly against these claims, but 
the fact remains that ﬁ nancing strategies need to factor 
in conditional lending by the IMF and other bodies, and 
involve such bodies in ongoing policy discussion.
ODA will continue to be an essential component of 
any future ﬁ nancing strategy, yet although it has steadily 
increased over the past decade, only ﬁ ve developed 
countries are currently achieving the target of 0·7% of 
gross national income, and in the country that most 
recently met the target—the UK—the political appetite 
for continued commitment to it is uncertain to say the 
least. A paper published in The Lancet Global Health last 
month explored the issue of “shared responsibility” as 
it pertains to the funding of HIV/AIDS programmes in 
12 sub-Saharan African countries that collectively absorb 
56% of total development assistance for AIDS. Robert 
Hecht and colleagues used a range of benchmarks such 
as AIDS’s share of government health expenditure being 
0·5 times AIDS’s share of total disease burden, and 
showed that several countries could be spending more 
domestic funds on HIV than they do currently. In the case 
of upper-middle-income countries such as South Africa, 
Namibia, and Botswana, such increases could potentially 
cover all national spending needs on AIDS. Other 
countries, however, would not nearly cover their needs, 
even with the most ambitious spending, emphasising the 
crucial role of ODA and other international and national 
ﬁ nancing channels going forward.
With the exception of research grants and fundraising 
in its most general sense, ﬁ nancial matters have not 
drawn much appeal from the global health community. 
But it is time to engage. We can’t all be economists, 
thankfully, but this year we might resolve to be a bit 
more economically savvy in our advocacy and research.
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